| Authors: |
Cachero S; Neurobiology Division, MRC Laboratory of Molecular Biology, Cambridge, UK. scachero@mrc-lmb.cam.ac.uk., Gkantia M; Neurobiology Division, MRC Laboratory of Molecular Biology, Cambridge, UK., Bates AS; Neurobiology Division, MRC Laboratory of Molecular Biology, Cambridge, UK., Frechter S; Neurobiology Division, MRC Laboratory of Molecular Biology, Cambridge, UK., Blackie L; Neurobiology Division, MRC Laboratory of Molecular Biology, Cambridge, UK.; MRC London Institute of Medical Sciences, Imperial College London, London, UK., McCarthy A; Neurobiology Division, MRC Laboratory of Molecular Biology, Cambridge, UK.; Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK., Sutcliffe B; Neurobiology Division, MRC Laboratory of Molecular Biology, Cambridge, UK., Strano A; Neurobiology Division, MRC Laboratory of Molecular Biology, Cambridge, UK.; Department of Cancer and Developmental Biology & Zayed Centre for Research into Rare Disease in Children, University College London, London, UK., Aso Y; Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA, USA., Jefferis GSXE; Neurobiology Division, MRC Laboratory of Molecular Biology, Cambridge, UK. jefferis@mrc-lmb.cam.ac.uk. |